Mary Elizabeth Hartnett,
MD
Languages Spoken: English
Mary Elizabeth Hartnett is a Doctor of Ophthalmology with a practice at the John A. Moran Eye Center at the University of Utah. She is the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair at the University of Utah Department of Ophthalmology and Visual Sciences and an Adjunct Professor at the University of Utah Departments of Neurobiology and Anatomy and Department of Pediatrics. Dr. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.
She received her undergraduate degree at Rensselaer Polytechnic Institute in Biology in the combined BS/MD program. She received her medical degree from Albany Medical College in the combined BS/MD program. Dr. Hartnett fulfilled post graduate training at Children’s Hospital and Schepens Eye Research Institute, Harvard University in molecular and cell biology and interned at University Hospitals of Cleveland. She completed a residency at University Hospitals of Cleveland, VA Medical Center in ophthalmology. She was awarded fellowships at Schepens Retina Associates and Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates in vitreoretinal medical/surgical training in adult retina. Dr. Hartnett also worked as a research fellow at Schepens Eye Research Institute, Harvard Medical School and at Harvard University as Senior research ophthalmology fellow. Other training includes St. Peter's Hospital in hospice team training.
Dr. Hartnett joined the Moran Eye Center in 2010 and will be building a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center. M.E. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.
Dr. Hartnett joined the Moran Eye Center in 2010 and has built a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center.
Clinical Locations
801-581-2352
Specialties
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor Neurobiology & Anatomy - Adjunct Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Pediatric Administration |
| Board Certification | American Board of Ophthalmology |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.6/ 5
Care provider spoke using clear language
4.6/ 5
Care provider's explanation of condition/problem
4.6/ 5
My confidence in care provider
4.7/ 5
Care provider's effort to include me in decisions
4.6/ 5
Wait time at clinic
3.6/ 5
Time care provider spent with me
4.4/ 5
Care provider's concern for questions & worries
4.7/ 5
Care provider's friendliness and courtesy
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 13, 2019
Just delightful Doctors ! Very positive !
UofU Patient
April 21, 2019
Dr. Hartnett always shows exceptional concern for my eye health and emotional issues.
UofU Patient
April 04, 2019
I liked the doctor did not liked the staff and the wait time
UofU Patient
April 04, 2019
everyone is amazing !
UofU Patient
November 11, 2018
This was the first time in a long period of time that I actually meant with my primary care doctor and it was quite helpful. Normally she reviews photos taken and makes the decision for when a needed appointment needs to take place but this time she went over my pictures and explained what was taking place with my eyes. It was a nice experience.
UofU Patient
November 11, 2018
Dr. Hartnett is a great Doctor. I know she will take the best care of my kids.
UofU Patient
November 09, 2018
I think Dr Harnett is great. She is thorough and straightforward. I read other bad reviews about bedside behavior before our visit and both times we've seen her, she has been kind, patient and straightforward. I think the ones who wrote those reviews were probably sensitive. She is great and I will continue to have my son see her.
UofU Patient
October 28, 2018
I would appreciate the use of simple terminology. The last year I have had to research the words my doctors tell me in my appointments and on mychart website.
UofU Patient
October 25, 2018
It was Dr. Eric Hansen and he did an excellent and thorough job of the examination and caring for me. I had concerns about something happening in my eye and through a thorough exam he was able to allay my fears and nothing bad that I feared has happened since then
UofU Patient
October 21, 2018
dr hartnett was great. she was patient and kind. she seemed to really care and wants to give us answers. very thorough.
UofU Patient
October 08, 2018
Dr Hartnett is wonderful
UofU Patient
October 06, 2018
GOOD
UofU Patient
September 13, 2018
Dr Hartnet was caring and very concerned about the macular hole. She was very thorough about what needed to be done to repair it. She listened as I discussed my negative experinces with my last surgery with another care provider. She didn't disparage the other provider, but she was firm in what she felt was the correct and ost successful way to handle the surgery and aftercare.
UofU Patient
September 04, 2018
My eye injection was changed to a stronger dosage. She took the time to explain that seeing if this worked better and explained that the outward experience of the injection would be the same.
UofU Patient
August 20, 2018
Dr Hartnett is a fabulous, caring, highly skilled doctor which is the reason I sought her out. She is overbooked and unable to give the attention she needs to each patient. We were never seen by her again after an additional test she requested to answer our questions. We left frustrated and highly disappointed after waiting almost two months to have an appointment.
UofU Patient
June 30, 2018
she is one of the best docs ever. she always explains everything to me. she is very skilled and I have total confidence in her
UofU Patient
June 26, 2018
Dr. Hartnett was very personable with my son during his visit. She was very thorough at explaining information and procedures. She was great to work with!
UofU Patient
June 22, 2018
I felt like she answered my specific questions briefly, but wasn't thorough with any explanation on this disease beyond my questions and stood next to the door, holding the handle as if she was in a hurry to get on to the next patient.
UofU Patient
May 14, 2018
Dr Hartnett showed great concern and caution in analyzing and exploring a side effect of my condition. She brought in additional resources to assess it and explored alternative solutions.
UofU Patient
April 30, 2018
Dr. Hartnett has always been extremely friendly and courteous. She explains everything very well and we have always been impressed with her care for our son ______.
UofU Patient
March 20, 2018
The PA that saw us first was very kind and patient with my two-year-old which I sincerely appreciate and was very impressed. Anyone with children know that toddlers do not have a long attention span or hold still. I wish I could remember this gentleman's name, but I can't. (He has red hair :0) I would give him high ratings as he worked very well with my young patient and was genuine and sincere. Our experience with the doctor was different. Although she was courteous, she was less than patient with my two-year-old. I recognize that the majority of patients are probably not that young, but still...After a toddler has been waiting for sometime while eyes are dilated and already having been seen by the PA, it would be difficult for a toddler to focus and hold still. Her lack of patience was evident. I felt the doctor's time was short and impersonal. I was expected to know everything about my child's condition already and my questions/concerns about upcoming procedures were not fully addressed. Our last visit was six months prior. I can't say that I remember or even know all those medical terms. More time spent in explaining my child's situation would have been helpful. More patience and understanding towards young patients would have made our experience a more positive one.
UofU Patient
March 10, 2018
she was very busy. she offered for us to Saturday after clinic to answer any questions. we chose not to. she was upfront and honest
UofU Patient
March 04, 2018
I feel like this app was an outlier however I am not happy with the visit, wait time and not being informed.
UofU Patient
February 17, 2018
Patients at Moran are most fortunate to be under the care of Dr. Hartnett and her staff.
UofU Patient
January 26, 2018
You are superstars in my opinion!
UofU Patient
January 18, 2018
This is our second visit with Dr. Hartnet, our first appt went very well. At this appt she was extremely short with her MA and when giving instructions to my child. The whole appt was very uncomfortable and she seemed very unprofessional.
UofU Patient
January 17, 2018
After waiting with our 4 month old and 3 year old for 1.5 hours, we were finally seen. We were placed into the procedure room, which seemed more like a storage room with old Starbucks beverages in the room. After the exam, it seemed as though there was no need for us to be in that room (maybe our children were being too loud)? The doctor came in and looked over the referral from the pediatric opthomologist that we saw in Rexburg, ID. The doctor then examined our daughter's eyes and did seem to get a good look at them. After that, she proceeded to type on her computer for approximately 2-3 minutes without saying a word or prompting us with any information as to why. She then diagnosed our daughter with a bilateral coloboma, which we were already aware of from the previous opthomologist we saw. After that, the disorganization and floodgates of information started flowing. I felt as though information was provided in spurts and I had to piece things together to try to understand. I felt as though I was being talked over and not provided with information that I understood. I also felt as though I was being provided with all the clinical research about this issue, and nothing personalized to my daughter. It would've been nice to be asked a question like "What do you see at home?" I am confident that the provider made all the necessary referrals and I am happy that the rest of the Moran Eye Center staff figured the rest out for us. Dr. Ricks stepped in and gave us great assistance
UofU Patient
December 11, 2017
We will always come here now. we have already told our friends and family.
UofU Patient
December 10, 2017
Dr. Hartnett is extremely compassionate and professional. greeting with a handshake is really nice. she always listens attentively and with genuine concern. I had to wait an hour to see her, but I guess that's okay because I truly value her expertise.
UofU Patient
December 05, 2017
The doctor seemed insensitive, clumsy, and hurried.
UofU Patient
November 09, 2017
it was a pleasure being there
UofU Patient
November 05, 2017
Dr. Hartnett is superb.
UofU Patient
October 23, 2017
Both the doctor and her assistant took the time to make sure that my concerns were addressed and I was put at ease over them.
UofU Patient
September 29, 2017
I would recommend Moran as well as Dr. Hartnett to anyone and everyone.
UofU Patient
August 09, 2017
All excellent.
UofU Patient
July 24, 2017
I appreciate the openness and honesty of Dr. Hartnett and her expertise. She ultimately gave us the decision on how to proceed but we trust her expert opinion and feel comfortable following her recommendations.
UofU Patient
July 15, 2017
Doctor Hartnett is wonderful. Before she came in, another doctor with a student named Juliann (I think?) examined my eye and drew Juliann's attention to things she should notice about my eye. The light was bright -- in fact, quite painfully bright. It further reminded me of how wonderful Doctor Hartnett is. She seems to dial back the intensity of the examination light to where I'm really not in much pain at all. (Same with Doctor Churgin). She really is wonderful and I'm so glad that she is in charge of treating my detached retinal condition.
UofU Patient
June 28, 2017
Due to the urgency of my injury, the providers spent a good deal of time making sure they got a good diagnosis and making sure I understood all of the steps toward recovery.
UofU Patient
June 25, 2017
I did not feel rushed. Dr. Hartnett is most professional and very compassiionate.
UofU Patient
June 15, 2017
We love Dr. Hartnett and Dr. Churgin (Churkin?)No medications after this visit.
UofU Patient
June 15, 2017
On Saturday, Dr., uh, Wellington, I think? Anyway, he was super nice and I think he answered all of _________'s (my wife) questions to her satisfaction.Also, before the surgery, I was still holding out hope that my eye was responding well enough to the earlier cryogenic treatment (I'm self pay, and was hoping to minimize costs). Dr. Hartnett was so sweet and had Dr. Churgin (Spelling?) take one last evaluation before doing the surgery. I really appreciated her doing that.
UofU Patient
June 06, 2017
the doctor did not speak with me after my surgery my husband contacted the doctor and asked several questions as to my aftercare and what he was supposed to do to get the adhesive off of my eyes so I could open my eyelids. We did not know that we had a appointment the next day the doctor informed my husband of this appointment on the phone.
UofU Patient
June 04, 2017
I felt secure in the decision to delay my diagnosis for 6 weeks because they took the time to explain this decision until I understood it. They understood I was very tired, my eyes were hurting and tired, but they were very patient with me. I appreciated this more than I can say.
UofU Patient
May 04, 2017
Dr Hartnett is excellent, you feel confident you are in good hands and she is also very calming
UofU Patient
March 19, 2017
superior
UofU Patient
February 09, 2017
I like Dr. Hartnett very much. I think she is extremely capable.
UofU Patient
December 27, 2016
We assumed that the doctor meant for us to continue with the eyedrops that our son was taking, but she didn't say so. We remembered to ask on our way out and had a surprisingly hard time getting an answer. From there began a saga that took several days to resolve (a prescription finally called in but for a different drug and with no explanation, etc.). A little bit of communication could have saved a lot of frustration.
UofU Patient
December 23, 2016
you are always recomanded
UofU Patient
October 28, 2016
excellent experience
UofU Patient
October 25, 2016
Dr. Hartnett was super. She is genuinely concerned about doing what is in my best interest.
UofU Patient
October 17, 2016
We have been very pleased with Hartnet and would recommend her and have.
UofU Patient
August 28, 2016
Medication (eye injection) was changed but care provider was not seen until injection and nothing was ever said about the change.
UofU Patient
July 31, 2016
I have never feel rushed during my exam.
UofU Patient
July 19, 2016
gpod
UofU Patient
June 05, 2016
I had a very bad experience with medical care 23 yrs ago when I lived in San Diego,Ca. I told myself I would never have any kind of surgery again unless my life depended on it. You folks are fantastic, from the receptionist to Dr Hartnett, everyone was truly wonderful and you changed my attitude towards medical providers, THANK YOU !
UofU Patient
June 03, 2016
if there was a score of 7 I would have given it in all cases!
UofU Patient
May 15, 2016
Dr. Hartnett and Dr. Warner are very knowledgeable. They have treated my brother so well giving him better vision and working also so well with my brother's Doctors team.
UofU Patient
May 01, 2016
excellent
UofU Patient
April 10, 2016
superior
UofU Patient
April 07, 2016
It was a very awesome experience and we very much appreciate those who helped us-you guys are terrific
UofU Patient
March 07, 2016
Just want to have this problem that seems to have stumped the doctors here at Moran. I wish they would reach out to other specialists perhaps at other great care Facilities for specific eye problems similar and perhaps other treatment options. I would be willing to travel anywhere to find some answers As to if my issue is permanent or a reasonable treatment available
UofU Patient
February 25, 2016
Excellent experience
UofU Patient
January 26, 2016
She's one of the best, most careful and most competent MD's I've ever known. She truly cares about her patients! Thank you Dr. Hartnett!
UofU Patient
January 22, 2016
After waiting 55 minutes in the waiting room, and another 15 in the exam room before we were seen, it was EXTREMELY frustrating and disheartening that we were told she only had a couple minutes before she had to run off to some other appointment that was obviously much more important than we were. We understand that things get behind, but the lack of respect that we were shown, the interest in answering our questions, and making sure we felt comfortable with what was happening, and what was to happen until the next appointment was awful!! Our time is just as important; and to be discarded like we felt we were is simply unacceptable!
UofU Patient
November 09, 2015
Dr. Hartnett always treats me courteously and answers questions. I was pleasantly surprised by her resident Dr. James (W?) who loved his work and was GREAT about providing information. I'm sorry I can't quite remember his last name.
UofU Patient
November 05, 2015
excellent experience
UofU Patient
October 26, 2015
couldn't have been a better experience
UofU Patient
October 06, 2015
over the top
UofU Patient
October 03, 2015
Hartnett and her team are wonderful!
UofU Patient
September 13, 2015
good
UofU Patient
September 06, 2015
Always kept me informed.
UofU Patient
August 03, 2015
I am just frustrated with the situation and how nothing is working and we are not seeing any progress.
UofU Patient
July 26, 2015
Dr. Hartnett is conscientious, concerned, caring, and I have full trust in her surgical skills, judgement, and expertise.
UofU Patient
July 26, 2015
Dr. Hartnett did speak over my head frequently, I had to use my daughter who is my caregiver and nurse to translate everything for me later on. Though Dr. Hartnett did address all of my concerns I did feel that she was rushing through to move on to her next patient.
UofU Patient
July 16, 2015
Both Dr Teske and Dr. Hartnett have been thorough and knowledgeable in my care of my two conditions. The system failure occurred through the failure of your phone system in forwarding my two calls to the on call physician when I experienced encroaching blindness of my left eye visual field.
UofU Patient
July 01, 2015
Dr, Hartnett spent a good amount of time explaining what was going on within my eye. I felt very reassured about the treatment. I felt she knew exactly what she was talking about and this put me at ease.
UofU Patient
July 01, 2015
Dr. Hartnett was absolutely amazing. She explained everything to me in laymen's terms and made sure I understand what needed to happen. Her manner was kind, confident and I felt she was personally concerned with what was happening to me.
UofU Patient
May 25, 2015
Dr. Hartnett was not able to answer some of my questions during my first appointment, so this time I brought a list. She is a very capable, kind human being, who was actually pleased that I brought a list of questions. She explained my issues very well. I would recommend her highly as a physician, and yet I am frustrated by the wait time I have experienced at Moran/University of Utah hospital. Yes, I want patients ahead of me to receive good health care also, and I want their issues to be resolved. At the same time, my visit is not enhanced by waiting in a stuffy dark room wondering what is going on. I think the U needs to seriously evaluate this scheduling problem.
UofU Patient
April 13, 2015
I like Mary Hartnett and have faith in her.
UofU Patient
February 09, 2015
Just a great facility and staff.
UofU Patient
January 23, 2015
Dr. Hartnett's office seems very organized . I have never spent much time waiting.
UofU Patient
January 21, 2015
Dr. Hartnet was excellent.
UofU Patient
January 12, 2015
As stated before it would be nice to get an update from the doctor on how she felt my eyes was responding to the treatment.
UofU Patient
December 15, 2014
No problem
UofU Patient
December 02, 2014
I did repeat my self 3 times ,same questions from the nurse then the intern then the Doctor , it gets a bit tedious but all were very good thanks
UofU Patient
November 29, 2014
I had a superb experience.
UofU Patient
November 16, 2014
every thing was taken care of very well.
UofU Patient
October 10, 2014
Dr. Hartnett is fantastic. So happy with everything she has done for my family. God bless her.
UofU Patient
September 12, 2014
Dr. Hartnett always shows genuine concern for my care, takes time to explain my options and helps me to make best decision. I very much appreciate her and those that work with her.
UofU Patient
July 31, 2014
excellent
UofU Patient
July 18, 2014
I would recommend Dr. Hartnett without hesitation.
UofU Patient
July 06, 2014
Dr. Hartnett has always been very good about communicating information and options. I feel that she genuinely cares about me as her patient.
UofU Patient
June 08, 2014
the MD was fine. The wait time is too long for me to recommend this facility to others for eye care.
UofU Patient
May 25, 2014
I was very impressed with doctors I saw, made a frightening experience not bad at all.
UofU Patient
May 25, 2014
Moran Eye Center is a great service to have so close by.
UofU Patient
May 19, 2014
Dr Hartnet is AMAZING!!!!
UofU Patient
April 28, 2014
GOOD EXPERIENCE
UofU Patient
March 30, 2014
Could have been better if physician and fellow examined at same time so I wouldn't have to have discomfort of lights twice.
UofU Patient
March 17, 2014
Doctor Hartnet is very professional and caring with patients--she includes me in decisions--I credit her with saving my sight in my right eye---she is an excellent physican----
UofU Patient
February 12, 2014
The care that I receive from Dr Hartnett is very good and she explains things well. However the assistant that dilated my eyes when they should not have been was not good at all.
UofU Patient
December 22, 2013
Dr. Hartnet was always very caring, engaged and helpful. A couple of her assistants/fellows (?) were less so and maybe even a little rough during exam of retinal tear (however, that may have been absolutely necessary. Dr. Hartnet was more gentle in her approach).
UofU Patient
November 28, 2013
I am usually seen by Dr. Hobbs and then by Dr. Hartnett. Both are very professional, and have done a wonderful job with my complicated case.
UofU Patient
November 18, 2013
Excellent.
UofU Patient
November 18, 2013
We would recommend Dr. Hartnett but the wait time was excessive. Also we were sent out to the reception waiting room and then called back into an exam room to schedule a procedure. We had to wait again for the person scheduling the procedure. It just seemed like the flow of how things ran there needed some work.
UofU Patient
November 11, 2013
Dr. B was awesome. He was straight forward explaining the situation to me abt what was happening and might happen with my retina. Too bad he couldn't/didn't need to stay longer and visit. I like him.
UofU Patient
October 21, 2013
I never saw the physician, just her fellow.
UofU Patient
October 14, 2013
I am always thankful for specialists. They have worked hard for their knowledge.
UofU Patient
October 07, 2013
Dr. Hartnett is clearly a consummate professional who is willing to explain and discuss my condition and the possible need for further treatment.
UofU Patient
October 07, 2013
Dr. Hartnett has been fantastic. She has done everything possible to deal with my difficult case with the best possible outcome.
UofU Patient
September 09, 2013
I have a problem with hearing when I can't see. Another thing I have a problem with is that by the time they actual DR comes in I am so dilated that I can't see the Dr.'s face. I don't know what she looks like.
UofU Patient
September 09, 2013
We drive 4 hours in order to see Dr. Lenahan, she is incredible to work with. I wouldn't want to see another provider even if they were "in-network"!
UofU Patient
September 02, 2013
okay. Primary Doctors time with us was limited
UofU Patient
August 08, 2013
Good
UofU Patient
July 15, 2013
I think there is a disconnect between me and the care provider. The care provider seems to be focusing her attention on my good eye where I really am still concerned with my bad eye. I could really use some help in knowing what I can do to minimize the symptoms or resolve the problem. I feel lost. I cannot describe the difficulties i've had in trying to cope with this and yet I feel like i'm left on my own to try and figure it out.
UofU Patient
June 05, 2013
I was unable to see the doctor - my contact lenses were out. But he was terrific. Very competent and patient.
UofU Patient
June 04, 2013
thanks to dr harnet my son can see!!!!!!!!!!!!!!
UofU Patient
April 01, 2013
everything was excellent except for the LONG wait.
UofU Patient
February 26, 2013
I am extremely impressed with the way doctor hartnett, and shokor(spelled wrong) diagnosed my problem. I've never been shown that kind and that much attention to any of my problems ever. Dr. Hartnett even came back after emergency surgery to make sure I was seen and looked at. I really felt like they cared and they wanted to make sure I was diagnosed correctly. My problem I know is a difficult one to diagnose, but I know they will find out what the problem is and help me. I would highly recommend others to go to the Moran eye center.
UofU Patient
February 18, 2013
Dr. Hartnet and the other doctor were very nice and thorough
UofU Patient
November 12, 2012
dr hartnet is the best pediatric retna specialist. she has a great bedside manner
UofU Patient
November 06, 2012
I have a serious retinal condition and these guys/gals knew what they were doing/talking about. Excellent facility.
UofU Patient
November 05, 2012
Dr. Hartnett pays such close attention my description of symptoms, and my physical exam is so meticulous. Her analysis of the situation is transparent which I appreciate.
Mary Elizabeth Hartnett is a Doctor of Ophthalmology with a practice at the John A. Moran Eye Center at the University of Utah. She is the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair at the University of Utah Department of Ophthalmology and Visual Sciences and an Adjunct Professor at the University of Utah Departments of Neurobiology and Anatomy and Department of Pediatrics. Dr. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.
She received her undergraduate degree at Rensselaer Polytechnic Institute in Biology in the combined BS/MD program. She received her medical degree from Albany Medical College in the combined BS/MD program. Dr. Hartnett fulfilled post graduate training at Children’s Hospital and Schepens Eye Research Institute, Harvard University in molecular and cell biology and interned at University Hospitals of Cleveland. She completed a residency at University Hospitals of Cleveland, VA Medical Center in ophthalmology. She was awarded fellowships at Schepens Retina Associates and Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates in vitreoretinal medical/surgical training in adult retina. Dr. Hartnett also worked as a research fellow at Schepens Eye Research Institute, Harvard Medical School and at Harvard University as Senior research ophthalmology fellow. Other training includes St. Peter's Hospital in hospice team training.
Dr. Hartnett joined the Moran Eye Center in 2010 and will be building a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center. M.E. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.
Dr. Hartnett joined the Moran Eye Center in 2010 and has built a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center.
Academic Locations
John A. Moran Eye Center
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor Neurobiology & Anatomy - Adjunct Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Pediatric Administration |
| Board Certification | American Board of Ophthalmology |
Education History
| Post Graduate Training | Children’s Hospital and Schepens Eye Research Institute, Harvard University Molecular and Cell Biology Postgraduate Studies |
| Fellowship | Schepens Retina Associates, Massachusetts Eye and Ear Infirmary, Harvard Medical School Vitreoretinal Medical/Surgical Training in Pediatric Retina Fellow |
| Research Fellow | Harvard University Senior Research Ophthalmology Fellow Research Fellow |
| Fellowship | Schepens Retina Associates Chief Fellow |
| Fellowship | Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates Vitreoretinal Medical/Surgical Training in Adult Retina Fellow |
| Research Fellow | Schepens Eye Research Institute, Harvard Medical School Research Fellow |
| Residency | University Hospitals of Cleveland, VA Medical Center Ophthalmology Resident |
| Internship | University Hospitals of Cleveland Intern |
| Professional Medical | Albany Medical College Medicine (Combined BS/MD program) M.D. |
| Undergraduate | Rensselaer Polytechnic Institute Biology (Combined BS/MD program) B.S. |
| Other Training | St. Peter's Hospital Hospice Team Training |
Selected Publications - Journal Articles
Journal Article
- Jeng-Miller KW, Soomro T, Scott NL, Rao P, Marlow E, Chang EY, Ells A, Chau F, Nudleman E, Calvo CM, Patel N, Schwartz R, Cernichiaro-Espinosa LA, Montoya AG, Goldstein J, Harper CA 3rd, Baumal CR, Hartnett ME, Harbour JW, Besirli CG, Gupta MP, Chan RVP, Drenser KA, Capone A Jr, Murray TG, Mukai S, Trese MT, Berrocal AM, Wong SC, Yonekawa Y (2019 Apr 1).
Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats' Disease With Widefield Fluorescein Angiography: A Multicenter Study.
. Ophthalmic Surg Lasers Imaging Retina, 50(4), 221-227. - Hartnett ME, Toth CA (2019 Apr 1).
Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity.
. Ophthalmic Surg Lasers Imaging Retina, 50(4), 228-234. - Yarishkin O, Phuong TTT, Bretz CA, Olsen KW, Baumann JM, Lakk M, Crandall A, Heurteaux C, Hartnett ME, Krizaj D (2018 Nov 16).
TREK-1 channels regulate pressure sensitivity and calcium signaling in trabecular meshwork cells.LID - jgp.201812179 [pii]LID - 10.1085/jgp.201812179 [doi]
. (Epub ahead of print) J Gen Physiol. - Greene T, Hartnett ME (2018 Oct 25).
Programming Error Led to Underestimate of Effect Sizes in Study of Association of Maternal Preeclampsia and Risk of Infant Retinopathy of Prematurity.LID - 10.1001/jamaophthalmol.2018.5055 [doi]
. (Epub ahead of print) JAMA Ophthalmol. - Shulman JP, Hartnett ME (2018 Sep-Oct).
Corrigendum: Pharmacotherapy and ROP: Going Back to the Basics.
. Asia Pac J Ophthalmol (Phila), 7(5), 365. - Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NL, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (2018 Aug 1).
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
. JAMA Ophthalmol, 136(8), 849-856. - Wallace DK, Dean TW, Hartnett ME, Kong L, Smith LE, Hubbard GB, McGregor ML, Jordan CO, Mantagos IS, Bell EF, Kraker RT (2018 Jun 7). A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.LID - S0161-6420(18)30491-3 [pii]LID - 10.1016/j.ophtha.2018.05.001 [doi]. (Epub ahead of print) Ophthalmology.
- Simmons AB, Bretz CA, Wang H, Kunz E, Hajj K, Kennedy C, Yang Z, Suwanmanee T, Kafri T, Hartnett ME (2018 May 5). Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.LID - 10.1007/s10456-018-9618-5 [doi]. (Epub ahead of print) Angiogenesis.
- Hartnett ME (2018 Mar 1). The Prematurity of Recommending Particular Polyunsaturated Fatty Acid Supplements for Retinopathy of Prematurity. JAMA Ophthalmol, 136(3), 277-278.
- Bretz CA, Divoky V, Prchal J, Kunz E, Simmons AB, Wang H, Hartnett ME (2018 Feb 1). Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization. Sci Rep, 8(1), 2161.
- Becker S, Wang H, Simmons AB, Suwanmanee T, Stoddard GJ, Kafri T, Hartnett ME (2018 Jan 31). Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms. Sci Rep, 8(1), 2003.
- Zhu W, Shi DS, Winter JM, Rich BE, Tong Z, Sorensen LK, Zhao H, Huang Y, Tai Z, Mleynek TM, Yoo JH, Dunn C, Ling J, Bergquist JA, Richards JR, Jiang A, Lesniewski LA, Hartnett ME, Ward DM, Mueller AL, Ostanin K, Thomas KR, Odelberg SJ, Li DY (2017 Oct 23). Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.LID - 10.1172/JCI91770 [doi]LID - 91770 [pii]. (Epub ahead of print) J Clin Invest.
- Shulman JP, Weng C, Wilkes J, Greene T, Hartnett ME (2017 Aug 10). Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity.LID - 10.1001/jamaophthalmol.2017.2697 [doi]. (Epub ahead of print) JAMA Ophthalmol.
- Hartnett ME (2017 Aug 01). Electroretinographic Responses in the Smallest Eyes. JAMA Ophthalmol, 135(8), 862-863.
- Kartchner JZ, Hartnett ME (2017 Jun). Familial exudative vitreoretinopathy presentation as persistent fetal vasculature. Am J Ophthalmol Case Rep, 6, 15-17.
- Todorich B, Thanos A, Yonekawa Y, Thomas BJ, Faia LJ, Chang E, Shulman J, Olsen KR, Blair MP, Shapiro MP, Ferrone P, Vajzovic L, Toth CA, Lee TC, Robinson J, Hubbard B, Kondo H, Besirli CG, Nudleman E, Wong SC, Kusaka S, Walsh M, Chan RVP, Berrocal A, Caputo G, Murray TG, Sears J, Schunemann R, Harper CA 3rd, Kychental A, Dorta P, Cernichiaro-Espinosa LA, Wu WC, Campbell JP, Martinez-Castellanos MA, Quiroz-Mercado H, Hayashi H, Quiram P, Amphornphruet A, Hartnett ME, Tsui I, Ells A, John V, Moshfeghi D, Capone A Jr, Drenser KA, Trese MT (2017 May). Correspondence. Retina, 37(5), e52-e54.
- Wallace DK, Kraker RT, Freedman SF, Crouch ER, Hutchinson AK, Bhatt AR, Rogers DL, Yang MB, Haider KM, VanderVeen DK, Siatkowski RM, Dean TW, Beck RW, Repka MX, Smith LE, Good WV, Hartnett ME, Kong L, Holmes JM (2017 Apr 27). Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study.LID - 10.1001/jamaophthalmol.2017.1055 [doi]. (Epub ahead of print) JAMA Ophthalmol.
- Nguyen J, Hartnett ME (2017 Apr). Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis. Am J Ophthalmol Case Rep, 5, 117-118.
- Becker S, Wang H, Yu B, Brown R, Han X, Lane RH, Hartnett ME (2017 Feb 14). Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birth. Sci Rep, 7, 42301.
- Hartnett ME (2017 Jan 30). Role of cytokines and treatment algorithms in retinopathy of prematurity.LID - 10.1097/ICU.0000000000000360 [doi]. (Epub ahead of print) Curr Opin Ophthalmol.
- Becker S, Wang H, Stoddard GJ, Hartnett ME (2017). Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model. Mol Vis, 23, 832-843.
- Friddle KM, Yoder BA, Hartnett ME, Henry E, DiGeronimo RJ (2017). Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity? Int J Pediatr, 2017, 9372539.
- Lambert NG, Hoffman RO, Hartnett ME (2016 Dec). A Case of Coats Disease and Concurrent Anisometropic Amblyopia. Am J Ophthalmol Case Rep, 4, 21-23.
- Sleath B, Sayner R, Vitko M, Carpenter DM, Blalock SJ, Muir KW, Giangiacomo AL, Hartnett ME, Robin AL (2016 Nov 22). Glaucoma patient-provider communication about vision quality-of-life.LID - S0738-3991(16)30545-6 [pii]LID - 10.1016/j.pec.2016.11.018 [doi]. (Epub ahead of print) Patient Educ Couns.
- Wang H, Han X, Kunz E, Hartnett ME (2016 Oct 01). Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 57(13), 5525-5534.
- Yonekawa Y, Wu WC, Kusaka S, Robinson J, Tsujioka D, Kang KB, Shapiro MJ, Padhi TR, Jain L, Sears JE, Kuriyan AE, Berrocal AM, Quiram PA, Gerber AE, Paul Chan RV, Jonas KE, Wong SC, Patel CK, Abbey AM, Spencer R, Blair MP, Chang EY, Papakostas TD, Vavvas DG, Sisk RA, Ferrone PJ, Henderson RH, Olsen KR, Hartnett ME, Chau FY, Mukai S, Murray TG, Thomas BJ, Meza PA, Drenser KA, Trese MT, Capone A Jr (2016 Aug). Immediate Sequential Bilateral Pediatric Vitreoretinal Surgery: An International Multicenter Study. Ophthalmology, 123(8), 1802-8.
- Carpenter DM, Sayner R, Blalock SJ, Muir KW, Hartnett ME, Lawrence SD, Giangiacomo AL, Goldsmith JA, Tudor GE, Robin AL, Sleath BL (2016 Aug). The Effect of Eye Drop Technique Education in Patients With Glaucoma. Health Commun, 31(8), 1036-42.
- Carpenter DM, Blalock SJ, Sayner R, Muir KW, Robin AL, Hartnett ME, Giangiacomo AL, Tudor GE, Sleath BL (2016 Jul). Communication Predicts Medication Self-Efficacy in Glaucoma Patients. Optom Vis Sci, 93(7), 731-7.
- Sayner R, Carpenter DM, Robin AL, Blalock SJ, Muir KW, Vitko M, Hartnett ME, Lawrence SD, Giangiacomo AL, Tudor G, Goldsmith JA, Sleath B (2016 Apr). How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Int J Pharm Pract, 24(2), 78-85.
- Wang H, Han X, Gambhir D, Becker S, Kunz E, Liu AJ, Hartnett ME (2016). Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization. PLoS ONE, 11(6), e0157748.
- Wang H, Han X, Bretz CA, Becker S, Gambhir D, Smith GW, Samulski RJ, Wittchen ES, Quilliam LA, Chrzanowska-Wodnicka M, Hartnett ME (2016). Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev, 3, 16056.
- Hartnett ME, Capone A Jr (2016). Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity. Eye Brain, 8, 27-29.
- Wang H, Han X, Wittchen ES, Hartnett ME (2016). TNF-alpha mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent beta-catenin activation. Mol Vis, 22, 116-28.
- Wang H, Fotheringham L, Wittchen ES, Hartnett ME (2015 Dec). Rap1 GTPase Inhibits Tumor Necrosis Factor-alpha-Induced Choroidal Endothelial Migration via NADPH Oxidase- and NF-kappaB-Dependent Activation of Rac1. Am J Pathol, 185(12), 3316-25.
- Sleath B, Carpenter DM, Blalock SJ, Sayner R, Muir KW, Slota C, Giangiacomo AL, Hartnett ME, Tudor G, Robin AL (2015 Oct). Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence. Health Educ Res, 30(5), 693-705.
- Basilius J, Young MP, Michaelis TC, Hobbs R, Jenkins G, Hartnett ME (2015 Sep). Structural Abnormalities of the Inner Macula in Incontinentia Pigmenti. JAMA Ophthalmol, 133(9), 1067-72.
- Sayner R, Carpenter DM, Blalock SJ, Robin AL, Muir KW, Hartnett ME, Giangiacomo AL, Tudor G, Sleath B (2015 Sep 01). Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Clin Ther, 37(9), 1975-85.
- Carpenter DM, Tudor GE, Sayner R, Muir KW, Robin AL, Blalock SJ, Hartnett ME, Giangiacomo AL, Sleath BL (2015 Jul 06). Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients.LID - S0738-3991(15)30010-0 [pii]LID - 10.1016/j.pec.2015.07.001 [doi]. (Epub ahead of print) Patient Educ Couns.
- Slota C, Sayner R, Vitko M, Carpenter DM, Blalock SJ, Robin AL, Muir KW, Hartnett ME, Sleath B (2015 May). Glaucoma patient expression of medication problems and nonadherence. Optom Vis Sci, 92(5), 537-43.
- Sleath B, Blalock SJ, Carpenter DM, Sayner R, Muir KW, Slota C, Lawrence SD, Giangiacomo AL, Hartnett ME, Tudor G, Goldsmith JA, Robin AL (2015 Apr). Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology, 122(4), 748-54.
- Sleath B, Sayner R, Blalock SJ, Carpenter DM, Muir KW, Hartnett ME, Tudor G, Lawrence S, Giangiacomo AL, Robin AL (2015). Patient question-asking about glaucoma and glaucoma medications during videotaped medical visits. Health Commun, 30(7), 660-8.
- Cabrera MT, Freedman SF, Hartnett ME, Stinnett SS, Chen BB, Wallace DK (2014 Nov-Dec). Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. Ophthalmic Surg Lasers Imaging Retina, 45(6), 542-8.
- Hartnett ME, Morrison MA, Smith S, Yanovitch TL, Young TL, Colaizy T, Momany A, Dagle J, Carlo WA, Clark EA, Page G, Murray J, DeAngelis MM, Cotten CM (2014 Aug 12). Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. Invest Ophthalmol Vis Sci, 55(10), 6194-203.
- Sleath BL, Blalock SJ, Muir KW, Carpenter DM, Lawrence SD, Giangiacomo AL, Goldsmith JA, Hartnett ME, Slota C, Robin AL (2014 Jul). Determinants of Self-Reported Barriers to Glaucoma Medicine Administration and Adherence: A Multisite Study. Ann Pharmacother, 48(7), 856-862.
- Carpter DM, Tudor GE, Sayner Rm, Muir KW, Robin AL, Blalock SJ, Hartnett ME, Giangiacomo ALK, Sleath BL (). Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients. Patient Educ Couns, 10(7), 2014.
- Sleath B, Slota C, Blalock SJ, Sayner R, Carpenter DM, Muir KW, Hartnett ME, Robin AL (2014 May). Provider use of collaborative goal setting with glaucoma patients. Optom Vis Sci, 91(5), 549-55.
- Yang Z, Wang H, Jiang Y, Hartnett ME (2014 Apr). VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis. Am J Pathol, 184(4), 1230-9.
- Jiang Y, Wang H, Culp D, Yang Z, Fotheringham L, Flannery J, Hammond S, Kafri T, Hartnett ME (2014 Feb 10). Targeting Muller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 55(2), 824-31.
- Wang H, Yang Z, Jiang Y, Flannery J, Hammond S, Kafri T, Vemuri SK, Jones B, Hartnett ME (2014 Feb 04). Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 55(2), 737-44.
- Owen LA, Hartnett ME (2014 Jan). Current concepts of oxygen management in retinopathy of prematurity. J Ophthalmic Vis Res, 9(1), 94-100.
- Wang H, Jiang Y, Shi D, Quilliam LA, Chrzanowska-Wodnicka M, Wittchen ES, Li DY, Hartnett ME (2014 Jan). Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization. FASEB J, 28(1), 265-74.
- Sleath B, Blalock SJ, Carpenter DM, Muir KW, Sayner R, Lawrence S, Giangiacomo AL, Hartnett ME, Tudor G, Goldsmith J, Robin AL (2014). Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits. J Ophthalmol, 2014, 238939.
- Wang H, Yang Z, Jiang Y, Hartnett ME (2014). Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Mol Vis, 20, 231-41.
- Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L (2013 Oct 04). MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem, 288(40), 28893-9.
- Wang H, Smith GW, Yang Z, Jiang Y, McCloskey M, Greenberg K, Geisen P, Culp WD, Flannery J, Kafri T, Hammond S, Hartnett ME (2013 Sep). Short hairpin RNA-mediated knockdown of VEGFA in Muller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity. Am J Pathol, 183(3), 964-74.
- Hartnett ME, Penn JS (). Mechanisms and management of retinopathy of prematurity. N Engl J Med, 368(12), 1162-3.
- Bressler SB, Quin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG Diabetic Retinopathy Clinical Research Network (). Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmol, 131(8), 1033-40.
- Hartnett ME, Owen L (). Soluble mediatros or diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. Curr Diab Rep, 13(4), 476-80.
- McCloskey M, Wang H, Jiang Y, Smith GW, Strange J, Hartnett ME (2013 Mar 21). Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 54(3), 2020-6.
- McCloskey M, Wang H, Jiang Y, Smith GW, Strange J, Hartnett ME (). Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of ROP. Invest Ophthalmol, 54(3), 2020-6.
- Hartnett ME, Lane R (). Effects of oxygen on the development and severity of retinopathy of prematurity. J AAPOS, 17(3), 229-34.
- Blair MP, Shapiro MJ, Hartnett ME (). Peripheral retinal nonperfusion in fellows eyes in Coats Disease. Retina.
- Wang H, Zhang SX, Hartnett ME (). Signaling pathways triggered by oxidative stess that mediate features of severe retinopathy of prematurity. JAMA Ophthalmol, 131(1), 80-5.
- Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L (). MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem, 288(40), 28893-9.
- Wang H, Zhang SX, Hartnett ME (2013 Jan). Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity. JAMA Ophthalmol, 131(1), 80-5.
- Wittchen ES, Nishimura E, McCloskey M, Wang H, Quilliam LA, Chrzanowska-Wodnicka M, Hartnett ME (2013). Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo. PLoS ONE, 8(9), e73070.
- Wang H, Jiang Y, Shi D, Quilliam LA, Chrzanowska-Wodnicka M, Wittchen ES, Li DY, Hartnett ME (). Activation of Rap1 inhibits NADPOH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization. FASEB J.
- Blair MP, Shapiro MJ, Hartnett ME (2012 Jun). Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children. J AAPOS, 16(3), 234-7.
- Blair MP, Shapiro MJ, Hartnett ME (). Fluorescein-anaiography to estimate normal peripheral retinal nonperfusion in children. J AAPOS, 16(3), 234-7.
- Bourne R, Price H, Stevens G, GBD Vision Loss Expert Group (). Global burden of visual impairment and blindness. Arch Ophthalmol, 130(5), 645-7.
- Wu C, Lofqvist C, Smith L, VanderVeen, Hellstrom A, WINROP Consortium (). Importance of Early Postnatal Weight Gain for Normal Retinal Angiogensis in Very Preterm Infants. Arch Ophthalmol, 1-8.
- Maile LA, Gollahon K, Wai C, Byfield G, Hartnett ME, Clemmons D (). Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes. Diabetologia, 55(3), 835-44.
- Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME (2012 Mar). VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol, 180(3), 1243-53.
- Maile LA, Gollahon K, Wai C, Byfield G, Hartnett ME, Clemmons D (2012 Mar). Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes. Pharmag, 55(3), 835-44.
- Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME (). VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol, 180(3), 1243-53.
- Moshirfar M, Hsu M, Schulman J, Armenia J, Sikder S, Hartnett ME (). The Incidence of Central Serous Chorioretinopathy after Photorefractive Keratectomy and Laser In Situ Keratomileusis. J Ophthalmol, 2012, 27-32.
- Moshirfar M, Hsu M, Schulman J, Armenia J, Sikder S, Hartnett ME (2012). The incidence of central serous chorioretinopathy after photorefractive keratectomy and laser in situ keratomileusis. J Ophthalmol, 2012, 904215.
- Wang H, Wittchen ES, Jiang Y, Ambati B, Grossniklaus HE, Hartnett ME (). Upregulation of CCR3 by Age-Related Stresses Promotes Choroidal Endothelial Cell Migration via VEGF-Dependent and Independent Signaling. Invest Ophthalmol Vis Sci, 52(11), 8271-7.
- Wang H, Wittchen ES, Jiang Y, Ambati B, Grossniklaus HE, Hartnett ME (2011 Oct 21). Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest Ophthalmol Vis Sci, 52(11), 8271-7.
- Moreno-Miralles I, Ren R, Moser M, Hartnett ME, Patterson C (). Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogensis in vivo in a mouse model of oxygen-induced retinopathy. Arterioscler Thromb Vasc Biol, (10), 2216-22.
- Moreno-Miralles I, Ren R, Moser M, Hartnett ME, Patterson C (2011 Oct). Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy. Arterioscler Thromb Vasc Biol, 31(10), 2216-22.
- Wittchen ES, Hartnett ME (2011 Sep 27). The small GTPase Rap1 is a novel regulator of RPE cell barrier function. Invest Ophthalmol Vis Sci, 52(10), 7455-63.
- Wittchen ES, Hartnett ME (). The small GTPase Rap1 is a novel regulator of RPE cell barrier function. Invest Ophthalmol Vis Sci, 52(10), 7455-63.
- Hartmann JS, Thompson H, Wang H, Kanekar S, Huang W, Budd SJ, Hartnett ME (). Expression of vascular endothelial growth factor and pigment epithelial derived factor in a rat model of retinopathy of prematurity.(EPub). Mol Vis, 1677-87.
- Wallace DK, Freedman SF, Hartnett ME, Quinn GE (). Predictive Value of Pre-plus Disease in Retinopathy of Prematurity. Arch Ophthalmol, 129(5), 591-6.
- Hartmann JS, Thompson H, Wang H, Kanekar S, Huang W, Budd SJ, Hartnett ME (). Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity. Mol Vis, 17(17), 1577-87.
- Wallace DK, Freedman SF, Hartnett ME, Quinn GE (2011 May). Predictive value of pre-plus disease in retinopathy of prematurity. Arch Ophthalmol, 129(5), 591-6.
- Howard DL, Kim MM, Hartnett ME (2011 Apr). Predicting glaucoma diagnosis in an elderly sample: revisiting the established populations for epidemiologic studies of the elderly. J Natl Med Assoc, 103(4), 332-41.
- Howard DL, Kim MM, Hartnet ME (). Predicting Glaucoma Diagnosis in an Elderly Sample: Revisiting the Established Populations for Epidemiologic Studies of the Elderly. J Natl Med Assoc, 103(4), 332-41.
- Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G (2011 Feb). Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology, 118(2), 345-52.
- Hartmann JS, Thompson H, Wang H, Kanekar S, Huang W, Budd SJ, Hartnett ME (2011). Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity. Mol Vis, 17, 1577-87.
- Wang H, Wittchen ES, Hartnett ME (2011). Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration. Eye Brain, 3, 19-28.
- Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G (). Standard Care versus Corticosteroid for Retinal Vein Occlusion Study Investigator Group. Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion: Standard Care versus Corticosteroid for Retinal Vein Occlusion: Standard Care versus Corticosteroid for Retinal Vein Occlusion study Report . SCORE Study Report 10. Ophthalmology, 118(2), 345-52.
- Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitoup SM, Ozurdex GENEVA Study Group, Li J (). Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology, 118(12), 2453-60.
- Wang H, Geisen P, Wittchen ES, King B, Burridge K, DAmore PA, Hartnett ME (2011 Jan). The role of RPE cell-associated VEGF(1)(8)(9) in choroidal endothelial cell transmigration across the RPE. Invest Ophthalmol Vis Sci, 52(1), 570-8.
- Hartnett ME (2010 Dec). Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis). Trans Am Ophthalmol Soc, 108, 96-119.
- Chan RV, Yonekawa Y, Morrison MA, Sun G, Wong RK, Perlman JM, Chiang MF, Lee TC, Hartnett ME, Deangelis MM (2010 Nov 26). Association between assisted reproductive technology and advanced retinopathy of prematurity. Clin Ophthalmol, 4, 1385-90.
- Hartnett ME (). RVO, AMD therapies make inroads. Ophthalmology Times, 35(23), 1, 22.
- Zayed MA, Uppal A, Hartnett ME (2010 Oct). New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 51(10), 4983-8.
- Monaghan-Benson E, Hartmann J, Vendrov AE, Budd S, Byfield G, Parker A, Ahmad F, Huang W, Runge M, Burridge K, Madamanchi N, Hartnett ME (). The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization. Am J Pathol, 177(4), 2091-102.
- Budd SJ, Thompson H, Hartnett ME (2010 Aug). Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Arch Ophthalmol, 128(8), 1014-21.
- ACCORD Study Group, ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis BP, Gangatrupa S, Grevan CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Geruth S, Gerstein HCV, Schubert U, Fine LJ (). Effects of medical therapies on reitnopathy progression in type 2 diabetes. N Engl J Med, 363(3), 233-44.
- Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (). Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology, 117(6), 1134-46.
- Diabetic Retinopathy Clinical Research Network, Elman MJ, Aletto LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott RJ, Stockdale CR, Sun JK (). Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology, 117(6), 1064-77.
- Hartnett ME (). Advancing technology helpful in pediatric retinal ophthalmology cases. Ocular Surgery News (US Edition), 6, 1385-90.
- Sleath B, Blalock SJ, Robin A, Hartnett ME, Covert D, DeVellis B, Giangiacomo A (2010 Apr). Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye (Lond), 24(4), 624-31.
- Hartnett ME (). The effects of oxygen stresses on the development of features of severe retinopahty of prematurity: knowledge from the 50/10 OIR model. Doc Ophthalmol, 120(1), 25-39.
- Budd SJ, Hartnett ME (2009 In Press). Increased Angiogenic Compounds during Persistent Avascular Retina in a Model of ROP. Arch Ophthalmol, 128(8), 1014-21.
- Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M, SCORE Study Research Group (). A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol, 127(9), 1101-14.
- Hartnett ME, Tinkham N, Paynter L, Geisen P, Rosenberg P, Koch G, Cohen KL (2009 Dec). Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol, 148(6), 895-901.e1.
- Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN, SCORE Study Investigator Group (). SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs. luer cone syringe design. Am J Ophthalmol, 148(5), 725-732.
- Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett ME (2009 Nov). Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res, 89(5), 718-27.
- Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J (2009 Jul 09). CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature, 460(7252), 225-30.
- Byfield G, Budd S, Hartnett ME (2009 Jul). The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest Ophthalmol Vis Sci, 50(7), 3360-5.
- Scott IU, Blodi BA, Ip MS, Vanveldhuisen PC, Oden NL, Chan CK, Gonzalez V (2009 Apr). SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type. Ophthalmology, 116(4), 756-61.
- Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C (2009 Mar). Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol, 127(3), 245-51.
- Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M (2009 Mar). SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology, 116(3), 504-12.
- Ulmasov B, Bruno J, Gordon N, Hartnett ME, Edwards JC (2009 Mar). Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway. Am J Pathol, 174(3), 1084-96.
- Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA 3rd (2009 Feb). Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol, 127(2), 132-40.
- Reynolds R, Hartnett ME, Rosner B, Atkinson J, Giclas PC, Seddon JM (2009 In Press). Plasma Complement Components and Activation Fragments are Associated with Age-Related Macular Degeneration Genotypes and Phenotypes. Invest Ophthalmol Vis Sci.
- Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H (2008 Aug). Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology, 115(8), 1366-71, 1371.e1.
- Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008 Jul). Vascular endothelial growth factor in eye disease. Prog Retin Eye Res, 27(4), 331-71.
- Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H (2008 Jul-Aug). A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina, 28(7), 919-30.
- Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL (2008 Jul). Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci, 49(7), 3107-14.
- Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, Fong DS, Foster WJ, Glassman AR, Hartnett ME, Kollman C, Li HK, Qin H, Scott IU (2008 May). Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci, 49(5), 1745-52.
- Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK (2008 May). Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol, 145(5), 894-901.
- Saito Y, Uppal A, Byfield G, Budd S, Hartnett ME (2008 Apr). Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest Ophthalmol Vis Sci, 49(4), 1591-8.
- Vinekar A, Trese MT, Capone A Jr (2008 Mar). Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol, 145(3), 548-555.
- Hartnett ME, Board RJ, Houghton O (2008 Mar). Subretinal hemorrhage after lens-sparing vitrectomy in infants born at or under 24 weeks gestation. Retina, 28(3 Suppl), S69-74.
- Geisen P, Peterson LJ, Martiniuk D, Uppal A, Saito Y, Hartnett ME (2008 Feb 11). Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis, 14, 345-57.
- Diabetic Retinopathy Clinical Research Network (2008). A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology, 115, 1445-1456.
- Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H (2008 Jan). Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina, 28(1), 36-40.
- Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, and Sinclair E, for the Studies of Ocular Complications of AIDS Research Group (2008). Poor predictive value of cytomegalovirus (CMV)-Specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis, 46, 458-466.
- Writing Committee for The Photographic Screening for Retinopathy of Prematurity Study Photo- ROP (2008). Primary Outcomes Ophthalmology. Retina, 28, S47-S54.
- Zayed MA, Yuan W, Leisner TM, Chalothorn D, McFadden AW, Schaller MD, Hartnett ME, Faber JE, Parise LV (2007 Nov 26). CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesis. Circ Res, 101(11), 1185-93.
- Bhavsar AR, Ip MS, Glassman AR (2007 Sep). The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol, 144(3), 454-6.
- Diabetic Retinopathy Clinical Research Network (2007). Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology, 114(8), 1520-5.
- Saito Y, Geisen P, Uppal A, Hartnett ME (2007 Jun 12). Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis, 13, 840-53.
- Diabetic Retinopathy Clinical Research Network (2007). Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol, 125(4), 469-80.
- Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett ME (2007 Apr). Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res, 84(4), 737-44.
- Diabetic Retinopathy Clinical Research Network (2007). Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology, 114(3), 525-36.
- Zeng G, Taylor SM, McColm JR, Kappas NC, Kearney JB, Williams LH, Hartnett ME, Bautch VL (2007 Feb 15). Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood, 109(4), 1345-52.
- Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Group (2007). Longitudinal Study of the Ocular Complications of AIDS. 2. Ocular examination results at enrollment. Ophthalmology, 114, 787-793.
- Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Group (2007). Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular diagnoses at enrollment. Ophthalmology, 114, 780-786.
- Steering Committee of Diabetic Retinopathy Clinical Research Network (2007). A phase 2 randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology, 114, 1860-1867.
- Diabetic Retinopathy Clinical Research Network (2006). Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol, 124(12), 1701-7.
- Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR (2006 Nov). Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 47(11), 4975-82.
- Hartnett ME, McColm JR (2006 Sep). Fibrovascular organization in the vitreous following laser for ROP: implications for prognosis. Retina, 26(7 Suppl), S24-31.
- Balasubramanian M, Capone A Jr, Hartnett ME, Pignatto S, Trese MT (2006 Sep). The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP): study design and baseline characteristics of enrolled patients. Retina, 26(7 Suppl), S4-10.
- Geisen P, McColm JR, King BM, Hartnett ME (2006 Sep). Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture. Curr Eye Res, 31(9), 739-48.
- McColm JR, Geisen P, Peterson LJ, Hartnett ME (2006 Aug). Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis. Exp Eye Res, 83(2), 438-46.
- Escaravage GK Jr, Cohen KL, Patel SB, Hartnett ME, Armstrong BD, Janowski CM (2006 May). Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg, 32(5), 803-11.
- Geisen P, McColm JR, Hartnett ME (2006 Apr). Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp Eye Res, 82(4), 608-19.
- PKC-DRS2 Group PI for LSU site (2006). Effect of Ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology, 113, 2221-2230.
- Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, for the Studies of Ocular Complications of AIDS Research Group (2006). Causes of Visual Acuity Loss Among Patients with AIDS and Cytomegalovirus in the Era of Highly Active Antiretroviral Therapy. Ophthalmology, 113, 1441-1445.
- Kempen JH, Min Y-I, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA for the Studies of Ocular Complications of AIDS Research Group (2006). Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology, 113, 684-694.
- Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB (2005 Mar). Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol, 123(3), 387-91.
- Hartnett ME, Maguluri S, Thompson HW, McColm JR (2004 Oct). Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina, 24(5), 753-7.
- McColm JR, Geisen P, Hartnett ME (2004 Jul 21). VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis, 10, 512-20.
- Van Cott EM, Laposata M, Hartnett ME (2004 Jul). Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis, 15(5), 393-7.
- Hartnett ME, McColm JR (2004 Apr). Retinal features predictive of progressive stage 4 retinopathy of prematurity. Retina, 24(2), 237-41.
- Jacobson MA, Maecker HT, Orr PL, DAmico R, Van Natta M, Li XD Pollard RB, Bredt BM for the Adult AIDS Clinical Trials Groupand the Studies of Ocular Complications of AIDS Research Group (2004). Results of a CMV-specific CD8+/IFNy+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis. J Infect Dis, 189, 1362-1373.
- Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK for the Studies of Ocular Complications of AIDS Research Group (2004). Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology, 111, 2232-2239.
- Marshall BC, Jacobson MA, Adler SP in collaboration with the Studies of Ocular Complications of AIDS Research Group (2004). Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitis. Viral Immunol, 17, 101-108.
- Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, DAmore PA (2003 Nov). Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res, 77(5), 593-9.
- Maguluri S, Hartnett ME (2003 Oct). Radial choroidal ruptures in sclopetaria. J Am Coll Surg, 197(4), 689-90.
- Hartnett ME, Rodier DW, McColm JR, Thompson HW (2003 Jul). Long-term vision results measured with Teller Acuity Cards and a new Light Perception/Projection Scale after management of late stages of retinopathy of prematurity. Arch Ophthalmol, 121(7), 991-6.
- Hartnett ME (2003 Jun). Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina, 23(3), 322-9.
- Hartnett ME, Laposata M, Van Cott E (2003 Apr). Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol, 135(4), 542-4.
- Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group (2003). The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy. Ophthalmology, 110, 987-995.
- Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D for the Studies of Ocular Complications of AIDS Research Group (2003). Visual loss in patients with cytomegalovirus retinitis and AIDS before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol, 121(1), 99-107.
- PhotoROP International Study Hartnett ME (2003). Photo Essay: Inadvertent Skip Areas in Treatment of Zone 1 Retinopathy of Prematurity. Retina, 23, 128-131.
- Miura M, Elsner AE, Beausencourt E, Kunze C, Hartnett ME, Lashkari K, Trempe CL (2002 Jun). Grading of infrared confocal scanning laser tomography and video displays of digitized color slides in exudative age-related macular degeneration. Retina, 22(3), 300-8.
- Beausencourt E, Remky A, Elsner AE, Hartnett ME, Trempe CL (2000 Feb). Infrared scanning laser tomography of macular cysts. Ophthalmology, 107(2), 375-85.
- Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D (2000 Feb). Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care, 23(2), 234-40.
- The STOP-ROP Multicenter Study Group (2000). Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A randomized, controlled trial. I: Primary Outcomes. Pediatrics, 105, 295-310.
- Andrews AP, Hartnett ME, Hirose T (1999 Winter). Surgical advances in retinopathy of prematurity. Int Ophthalmol Clin, 39(1), 275-90.
- Sheindlin JA, Hirose T, Hartnett ME (1999 Winter). Ophthalmic endoscopy: applications in intraocular surgery. Int Ophthalmol Clin, 39(1), 237-47.
- Hartnett ME, Garcia CM, DAmore PA (1999 Nov). Release of bFGF, an endothelial cell survival factor, by osmotic shock. Invest Ophthalmol Vis Sci, 40(12), 2945-51.
- Remky A, Beausencourt E, Hartnett ME, Trempe CL, Arend O, Elsner AE (1999 Nov). Infrared imaging of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol, 237(11), 897-901.
- Kunze C, Elsner AE, Beausencourt E, Moraes L, Hartnett ME, Trempe CL (1999 Sep). Spatial extent of pigment epithelial detachments in age-related macular degeneration. Ophthalmology, 106(9), 1830-40.
- Armstrong D, Ueda T, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R, Dorey CK (1998). Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis, 2(1), 93-104.
- Hartnett ME, Hirose T (1998). Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children. Retina, 18(2), 125-9.
- Beausencourt E, Elsner AE, Hartnett ME, Trempe CL (1997 Dec). Quantitative analysis of macular holes with scanning laser tomography. Ophthalmology, 104(12), 2018-29.
- Armstrong D, Ueda To, Ueda Ta, Browne R, Al-Jada A, Spengler R, Chou R, Fukuda S, Buch P, Dandona P, Hartnett ME, Sasisekharan R, Dorey KC (1997). Expression of TNF-alpha and VEGF during retinal neovascularization is initiated by lipid hydroperoxide. Angiogenesis, 2, 174-84.
- Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE (1996 Dec). Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology, 103(12), 2042-53.
- Steidl SM, Hirose T, Sang D, Hartnett ME (1996). Difficulties in excluding the diagnosis of retinoblastoma in cases of advanced Coats' disease: a clinicopathologic report. Ophthalmologica, 210(6), 336-40.
- Hartnett ME, Elsner AE (1996 Jan). Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology, 103(1), 58-71.
- Steidl S, Hirose T, Hartnett ME (1995 Winter). Open-sky vitrectomy for posterior segment reconstruction in eyes with severe trauma. Int Ophthalmol Clin, 35(1), 175-80.
- Hartnett ME, Pruett RC, DaSilva KC, Burkart PT (1994 Sep 15). Antiphospholipid antibody syndrome associated with microscotomata. Am J Ophthalmol, 118(3), 397-8.
- Hartnett ME, Katsumi O, Hirose T, Richardson TM, Walton DS (1994 Jan 15). Improved visual function in retinopathy of prematurity after lowering high intraocular pressure. Am J Ophthalmol, 117(1), 113-5.
- Hartnett ME, Coles WH (1993 Aug 15). Lens clarity after vitrectomy in traumatic lens perforation and vitreous penetration. Am J Ophthalmol, 116(2), 250-1.
- Hartnett ME, Gilbert MM, Hirose T, Richardson TM, Katsumi O (1993 Aug). Glaucoma as a cause of poor vision in severe retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol, 231(8), 433-8.
- Hartnett ME, Hirose T, Richardson TM, Garsd A, Gilbert MM, Krug J Jr (1992). Intraocular pressure determination in infants with severe retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol, 230(5), 406-10.
- Hartnett ME, Weiter JJ, Garsd A, Jalkh AE (1992). Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol, 230(1), 11-9.
- Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose T (1990 Jan). Anterior segment evaluation of infants with retinopathy of prematurity. Ophthalmology, 97(1), 122-30.
- Lazarus HM, Hartnett ME, Reed MD, Murphy BF, Lass JH (1987 Nov 15). Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis. Am J Ophthalmol, 104(5), 476-80.
- Mangan KF, Hartnett ME, Matis SA, Winkelstein A, Abo T (1984 Feb). Natural killer cells suppress human erythroid stem cell proliferation in vitro. Blood, 63(2), 260-9.
- Krohel GB, Tobin DR, Hartnett ME, Barrows NA (1982 Oct). Divergence paralysis. Am J Ophthalmol, 94(4), 506-10.
Review
- Shulman JP, Hartnett ME (2018 May-Jun). Pharmacotherapy and ROP: Going Back to the Basics. [Review]. Asia Pac J Ophthalmol (Phila), 7(3), 130-135.
- Calvo CM, Hartnett ME (2018). The utility of ultra-widefield fluorescein angiography in pediatric retinal diseases. [Review]. Int J Retina Vitreous, 4, 21.
- Wang H, Hartnett ME (2017 Jun 03). Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects.LID - E40 [pii]LID - 10.3390/antiox6020040 [doi]. [Review]. Antioxidants (Basel), 6(2).
- Hartnett ME (2016 Dec 21). ADVANCES IN UNDERSTANDING AND MANAGEMENT OF RETINOPATHY OF PREMATURITY.LID - S0039-6257(16)30114-X [pii]LID - 10.1016/j.survophthal.2016.12.004 [doi]. [Review]. Surv Ophthalmol.
- Wang H, Hartnett ME (2016). Regulation of signaling events involved in the pathophysiology of neovascular AMD. [Review]. Mol Vis, 22, 189-202.
- Hartnett ME, Cotten CM (2015 Dec). Genomics in the neonatal nursery: Focus on ROP. [Review]. Semin Perinatol, 39(8), 604-10.
- Hartnett ME (2015 Jan). Pathophysiology and mechanisms of severe retinopathy of prematurity. [Review]. Ophthalmology, 122(1), 200-10.
- Hartnett ME (2014 Dec). Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. [Review]. Clin Perinatol, 41(4), 925-43.
- Owen LA, Hartnett ME (2013 Aug). Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. [Review]. Curr Diab Rep, 13(4), 476-80.
- Hartnett ME, Lane RH (2013 Jun). Effects of oxygen on the development and severity of retinopathy of prematurity. [Review]. J AAPOS, 17(3), 229-34.
- Hartnett ME, Penn JS (2012 Dec 27). Mechanisms and management of retinopathy of prematurity. [Review]. N Engl J Med, 367(26), 2515-26.
Edited Book
- Hartnett ME, ed-in-chief (Eds.) (2005). Pediatric Retina. Philadelphia, PA: Lippincott Williams & Wilkins.
- Steidl S, Hartnett ME (Eds.) (2003). Clinical Pathways in Vitreoretinal Disease. New York, NY: Thieme Publishers.
- Schepens CL, Hartnett ME, Hirose T (Eds.) (2000). Schepens’ Retinal Detachment and Allied Diseases. (2nd edition). Boston, MA: Butterworth-Heinemann.
Book Chapter
- ME Hartnett (). The Effects of Hypoxia, Hyperoxia, and Oxygen Fluctuations on Oxidative Signaling in the Preterm Infant and Retinopathy of Prematurity. Oxidative Stress and Antioxidant Protection. In Donald Armstrong and Robert D. Stratton, John Wiley and Sons (Eds.), The Science of Free Radical Biology and Disease. Hoboken, New Jeersey.
- ME Hartnett (). Pathophysiology of ROP. β. In Andres Kychenthal and Paola Dort. (Eds.), Retinopathy of Prematurity. New York, New York: Springer Science and Business Media.
- Hartnett ME (). The Role of Reactive Oxygen Species and Oxidative Signaling in Retinopathy of Prematurity. In Studies on Retinal and Choroidal Disorders.
- Hartnett ME, Toth CA (). Retinopathy of Prematurity. In Levin and Albert (Eds.), Ocular Disease: Mechanisms and Management (pp. 562-571). London, UK.
- Hartnett ME (). Breakdown of the blood: RPE barrier. In Hodges R, Dartt D, editor-in-chief, D'Amore P, editor (Eds.), Encyclopedia of the Eye (1, pp. 223-232). Elsevier, Inc.
- Hartnett ME (). Retinal Vasculopathies: retinopathy of prematurity. In Hodges R and Dartt D, editor-in-chief, Bok D (Eds.), Encyclopedia of the Eye (3, 3, pp. 118-128). Elsevier, Inc.
- Oh K, Hartnett ME, Landers ML (2005). Pathogenetic Mechanisms of Retinal Detachment. In Ryan S (Ed.), Retina (4th edition, pp. 2013-2020).
- McColm J, Hartnett ME (2005). Retinopathy of Prematurity: Current Understanding Based on Clinical trials and Animal Models. In Hartnett ME (Ed.), Pediatric Retina (2nd, pp. 387-409). Philadelphia, PA: Lippincott Williams & Wilkins.
- Capone A, Hartnett ME, Trese MT (2005). Treatment of Retinopathy of Prematurity: Peripheral Retinal Ablation and Vitreoretinal Surgery. In Hartnett ME (Ed.), Pediatric Retina (pp. 417-424). Philadelphia, PA: Lippincott Williams & Wilkins.
- Hartnett ME (2003). Diagnosis and Examination of the Pediatric Patient. In Steidl S, Hartnett ME (Eds.), Clinical Pathways in Vitreoretinal Disease (pp. 341-373). New York, NY: Thieme Publishers.
- Hartnett ME (2000). Prophylaxis of retinal detachment. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 271-288). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Basic considerations of preoperative patient management and technical aspects of chorioretinal adhesion. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 257-270). Boston, MA: Butterworth-Heinemann.
- Schepens CL, Hartnett ME (2000). Macular breaks and other macular changes. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 435-455). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Vitreoretinal traction forces: special situations and methods of management. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 355-365). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Primary rhegmatogenous retinal detachment. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 291-346). Boston, MA: Butterworth-Heinemann.
- Hartnett ME, Hirose T (2000). Retinal detachment in the pediatric population. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 515-554). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Managing the crystalline lens and intraocular lenses. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 555-565). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Surgical indications for retinal detachment associated with diabetic eye disease. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 659-669). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Other traction retinal detachments. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 671-676). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Complications. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 721-740). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Philosophy of retinal detachment management. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 347-353). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Trauma classification and management. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 689-705). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Reoperations. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 367-392). Boston, MA: Butterworth-Heinemann.
- Hartnett ME (2000). Evaluation of the traumatized eye. In Schepens CL, Hartnett ME, Hirose T (Eds.), Schepens’ Retinal Detachment and Allied Diseases (2nd edition, pp. 679-687). Boston, MA: Butterworth-Heinemann.
- Elsner AE, Bartch D-U, Weiter JJ and Hartnett ME (1999). New devices in retinal imaging and functional evaluation. In Freeman W (Ed.), Practical Atlas of Retinal Disease and Therapy (2nd edition, pp. 19-55). NY: Lippincott-Raven.
- Armstrong D, Ueda To, Ueda Ta, Hiramitsu T, Stockton R, Browne R, Al-Jada A, Buch P, Hartnett ME (1998). Dose dependent mechanisms of lipid hydroperoxide induced retinal pathology. In Yagi K (Ed.), Pathophysiology of Lipid Peroxides and Related Free Radicals (pp. 57-76). Tokyo: Japan: Scientific Societies Press.
- Hartnett ME (1996). Ocular manifestations of the acquired immunodeficiency syndrome. In Hunt JW (Ed.), Medicine for the Practicing Physician (pp. 1951-1953). Norwalk, CT: Appleton and Lange, Simon and Schuster.
- Hartnett ME (1996). Age-related macular degeneration. In Hunt JW (Ed.), Medicine for the Practicing Physician (pp. 1954-1956). Norwalk, CT: Appleton and Lange, Simon and Schuster.
- Hartnett ME (1996). Retinal detachment. In Hunt JW (Ed.), Medicine for the Practicing Physician (pp. 1946-1948). Norwalk, CT: Appleton and Lange, Simon and Schuster.
- Hartnett ME (1996). Diabetic retinopathy. In Hunt JW (Ed.), Medicine for the Practicing Physician (pp. 1924-1927). Norwalk, CT: Appleton and Lange, Simon and Schuster.
Conference Proceedings
- Elsner AE, Burns SA, Weiter JJ, Hartnett ME (1994). Diagnostic application of near infrared solid-state lasers in the eye. LEOS 1994 Conference Proceedings, IEEE Cat. No. 94 CH3371-2, 14-15.
- Hartnett ME, Katsumi O, Hirose T, Richardson T (Nov. 18-19, 1993). Increased intraocular pressure as a cause of delayed visual development in infants with severe retinopathy of prematurity. International Conference on Retinopathy of Prematurity, Chicago, IL.
- Hartnett ME, Hirose T, Gilbert MM, Krug JH, Richardson TM (June 9, 1990). Early detection of glaucoma in prematurity. Schepens Alumni Society Meeting, Boston, MA.
Case Report
- Xu M, Gelowani V, Eblimit A, Wang F, Young MP, Sawyer BL, Zhao L, Jenkins G, Creel DJ, Wang K, Ge Z, Wang H, Li Y, Hartnett ME, Chen R (2015 Jun). ATF6 Is Mutated in Early Onset Photoreceptor Degeneration With Macular Involvement. Invest Ophthalmol Vis Sci, 56(6), 3889-95.
- Young MP, Sawyer BL, Hartnett ME (2014 Apr). Ophthalmologic findings in an 18-month-old boy with focal dermal hypoplasia. J AAPOS, 18(2), 205-7.
Editorial
- Hartnett ME, Baehr W, Le YZ (2017 Aug 04). Diabetic retinopathy, an overview.LID - S0042-6989(17)30142-6 [pii]LID - 10.1016/j.visres.2017.07.006 [doi]. Vision Res.
- Christensen RD, Ilstrup SJ, Hartnett ME (2014 Apr). Retinopathy of prematurity and transfusion practice. Transfusion, 54(4), 960-1.
Letter
- Hartnett ME, Lane R (2013 Dec). Reply: To PMID 23791404 [Letter to the editor]. J AAPOS, 17(6), 652.
- Hartnett ME, Penn JS (2013 Mar 21). Mechanisms and management of retinopathy of prematurity [Letter to the editor]. N Engl J Med, 368(12), 1162-3.
- Martiniuk D, Geisen P, Hartnett ME (2006). Invited Author Response to Letter titled “Purification of triamcinolone acetonide suspension for intravitreal use.” [Letter to the editor]. Invest Ophthalmol Vis Sci.
- Hartnett ME, McColm JR (2005 Sep). Diode laser for ROP [Letter to the editor]. Ophthalmology, 112(9), 1636; author reply 1636.
- Hartnett ME (2004). Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity [Letter to the editor]. Retina, 24, 658.
Abstract
- Yang Z, Wang H, Jiang Y, Mccloskey M, Hartnett ME (). The combined effect with Erythropoietin and VEGF in retinal angiogenesis. The Association for Research in Vision and Ophthalmology (ARVO). Seattle, Washington [Abstract].
- Wang H, McCloskey M, Wittchen ES, Hartnett ME (). Activation of Rap1 prevents tumor necrosis factor alpha-induced ROS generation in RPE. The Association for Research in Vision and Ophthalmology (ARVO). Seattle, Washington [Abstract].
- Jiang Y, McCloskey, Wangg H, Yangg Z, Strange J, Kafir T, Flannery JG, Greenverg K, Hammond S, Hartnett ME (). Knockdown of Muller cell specific VEgf reduces retinal neovascularizationin a rat model of retinopnopathy of prematurity [Abstract].
- Hartnett ME, Morrison M, Page G, Cotten M, Murray J, DeAngeles M (). Candidate Gene Study of Retinopathy of Prematurity in Extremely Low Birthweight Infants from the Neonatal Research Network. The Association for Research in vision and Ophthalmology (ARVO). Seattle, Washington [Abstract].
- Wang H, Nishimura E, McCloskey M, Wittchen ES, Hartnett ME (). Activation of Rap1 reduces Reactive Oxygen Species in Retinal Pigmen Epithelium and Choroidal Neovascularization in an Animal Model. The American Ophthalmology Society (AOS). Charleston, SC [Abstract].
- Hartnett ME (). Intrauterine Growth Restriction Alters Retinal IGF-1 Levels in Newborn Rats. ARVO. Ft. Lauderdale, FL [Abstract].
- Shulman JP, Sider S, Moshirfar M, Harrie R, Hartnett ME (). Success of Early Limited Core Vitrectomy in Double Penetrating Globe Injuries [Abstract].
- Hartnett ME, Jiang Y, Hale M, Wang H, Smith GW (). Intrauterine Growth Restriction Alters Retinal IGF-1 Levels in Newborn Rats [Abstract].
- Smith GW, Culp WD, Byfield G, Kafri T, Flannery J, Hartnett ME (). Targeting Mueller Cell-derived VEGF With Short Hairpin RNA [Abstract].
- Hartnett ME (). Success of early limited core Vitrectomy in double Penetrating Glove Injuries. ARVO. Ft. Lauderdale, FL [Abstract].
- Hartnett ME (). Targeting Mueller cell-derived VEGF with short hairpin RNE. ARVO. Ft. Lauderdale, FL [Abstract].
- Haibo W, Byfield G, Hartnett ME (). Vegf Mediated Stat3 Activation Contributes To Retinal Avascularity In Rat Model Of Rop [Abstract].
- Hartnett ME (). Rap 1 GTPase is involved in RPE Cell Barrier Function. ARVO. Ft. Lauderdale, FL [Abstract].
- Nishimura E, McCloskey M, Jiang Y, Smith GW, Wang H, Hartnett ME (). The Effect of Laser-Induced CNV in Rap1b-deficient Mice [Abstract].
- Wittchen ES, Burridge K, Hartnett ME (). Rap1 GTPass Is Involved In RPE Cell Barrier Function [Abstract].
- Hartnett ME (). VEGF Mediated Stat3 Activation Contributes to Retinal Avascularity in Rat Model of ROP. ARVO. Ft. Lauderdale, FL [Abstract].
- Hartmann J, Huang W, Budd S, Barton K, Richardson A, Hartnett ME (). Modulation of Vascular Endothelial Growth factor and Pigment Epithelial Derived Factor by alternating periods of hyperoxia and hypoxia in a relevant model of retinopahty of prematurity [Abstract].
- Ulrich JN, Moyer S, Hartnett ME (). Characteristics and Treatment Outcomes of Pediatric Retinal Vascular Malformations [Abstract].
- Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME (). Baseline Factors Predictive of visual Acuity and Central Retinal thickness outcomes in Patients with Macular Edema Secondary to Retinal Vein Occlusions in the Standard are versus corticosteroid for Retinal Vein Occlusion (SCORE) Study [Abstract].
- Reynolds R, Hartnett ME, Rosner B, Atkinson J, Giclas PC, Seddon JM (May 5, 2009). Plasma Complement Proteins are Associated with AMD Genotypes and Phenotypes [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3445/D777.
- Budd S, Parker A, Hartnett ME (May 5, 2009). NAC Decreases Reactive Oxygen Species Production for in-vitro Choroidal Endothelial Cells Stimulated With VEGF [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3841/A134.
- Byfield G, Parker A, Budd S, Hartnett ME (May 3, 2009). In the Presence of VEGF, Choroidal Endothelial Cells Increase Production of Reactive Oxygen Species in a Dose and Time Dependent Manner [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 1187/D1149.
- Zayed MA, Uppal A, Wells MB, Rodriguez D, Hartnett ME (September 26, 2008). Effects of Maternal Pre-eclampsia on Severity of Infant Retinopathy of Prematurity [Abstract]. The Retina Society, Scottsdale, AZ.
- Budd SJ, Cheney RE, Hartnett ME (2008). Intravitreous Injections of a VEGF Receptor 2 Inhibitor Reduces Filopodia Length in Endothelial Tip Cells in the Rat Model of Oxygen Induced Retinopathy [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 516/A442.
- Byfield G, Hartnett ME (2008). Signaling Through gp130 and the JAK/STAT Pathway Play a Role in Intravitreous Neovascularization and VEGF Expression in the OIR Rat Model [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 532/A458.
- Martiniuk DJ, Zhao Z, Wallace DK, Hartnett ME (2008). Reducing the Bioactivity of VEGF With a Neutralizing Antibody Significantly Reduces Arteriole Tortuosity in a Rat Model of Oxygen - Induced Retinopathy [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 1409/A579.
- Geisen P, Wittchen E, Hartnett ME (2008). Vegf 189 Isoform Is Preferentially Upregulated in Retinal Pigment Epithelium Upon Contact With Choroidal Endothelial Cells [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 862/D680.
- Culp W Jr, Budd S, Geisen P, Lu X, Saito Y, Hartnett ME (2008). The Role of Vegf164 in Intravitreous Neovascularization Using a Rat Model of Oxygen Induced Retinopathy [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 2637/A362.
- Zayed MA, Wells MB, Rodriguez D, Hartnett ME (2008). Maternal Pre - Eclampsia Contributes to the Severity of Infant Retinopathy of Prematurity [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 1392/A562.
- Watson J, Garg S, Hartnett ME (2008). Clinical Outcomes From Intravitreal Bevacizumab Injection [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 318/D639.
- Peterson LJ, Geisen P, Saito Y, Lu X, Martiniuk D, Cui G, Hartnett ME (2007). Neutralizing Antibody to VEGF164 Reduces IVNV and Capillary Density in a Rat Model of Oxygen-Induced Retinopathy [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3411/B558.
- Geisen P, Zayed M, Parise LV, Hartnett ME (2007). Vegf 189 Isoform Plays an Important Role in Retinal Pigment Epithelium/Choroidal Endothelial Cell Transmigration [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 2526/B473.
- Uppal A, Saito Y, Sutton DK, Geisen P, Cui G, Peterson LJ, Hartnett ME (2007). Effects of Supplemental Oxygen Treatment on Oxygen-Induced Retinopathy in Neonatal Rats [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3410/B557.
- Sutton DK, Martiniuk D, Geisen P, Peterson L, Saito Y, Hartnett M (2007). Intravitreous Triamcinolone Injection Significantly Increases Retinal Arterial Tortuosity in the Rat Oxygen-Induced Retinopathy Model [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3406/B553.
- Saito Y, Uppal A, Sutton DK, Geisen P, Cui G, Lu X, Peterson LJ, Hartnett ME (2007). Effects of Systemic Inhibition of Reactive Oxygen Species on Oxygen-Induced Retinopathy in Neonatal Rats [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3408/B555.
- Rosenberg P, Radionchenko Y, Geisen P, NDure F, Cohen K, Thompson H, Hartnett M (2007). Predictors of Postoperative Macular Edema in Diabetic and Nondiabetic Patients Undergoing Phacoemulsification-6 Month Results [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 1393/B449.
- Martiniuk DJ, McColm JR, Geisen P, Peterson LJ, Saito Y, Smith W, Hartnett ME (2006). Triamcinolone acetonide reduces intravitreous neovascularization and central capillary density in a rat model of oxygen induced retinopathy in neonatal rats [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Zayed, MA, McFadden, A, Yuan, W, Hartnett, ME, Chalothorn, D, Faber, J, and Parise, LV (2006). Critical Role of CIB1 in Endothelial Cell Function and In Vivo Ischemia-Induced Angiogenesis [Abstract]. Blood, 108(11).
- Rosenberg P, Radionchenko Y, McColm J, Geisen P, Cohen K, Thompson H, Vallar C, Hartnett M (2006). Predictors of postoperative macular edema in diabetic patients undergoing phacoemulsification [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Peterson LJ, Geisen P, McColm JR, Wittchen E, Burridge K, Hartnett ME (2006). The role of RPE matrix and RPE contact in choroidal endothelial cell migration [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- King B, Geisen P, McColm JR, Peterson L, Hartnett ME (2006). VEGF isoform expression in RPE in transmigration of primary human choroidal endothelial cells across ARPE-19 [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- McColm JR, Geisen P, Hartnett ME (2005). Exogenous Leukemia Inhibitory Factor Attenuates Retinal Vascularization [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Geisen P, McColm JR, Hartnett ME (2005). Soluble Vascular Endothelial Growth Factor Promotes Endothelial Cell Transmigration Across the Retinal Pigment Epithelium [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Hartnett ME, Geisen P, McColm JR, Wittchen ES, Burridge K (2005). PI 3-kinase mediates Choroidal Endothelial Cell Transmigration of the Retinal Pigment Epithelium and Involves Active Rac [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Escaravage GK, Cohen KL, Patel SB, Hartnett ME, Armstrong BB, Janowski CM (2005). Quantitation of Perifoveal and Optic Disc Hyperfluorescence After Phaco and pcIOL in Patients With Diabetes Mellitus [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Geisen P, McColm JR, Hartnett ME (2004). Retinal Cell Injury in a Rat Model of Retinopathy of Prematurity [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 737, 29.
- Escaravage GK, Cohen KL, Hartnett ME, Patel SB, Armstrong BB, Janowski CM (2004). Diabetic Retinopathy, Visual Acuity, and Quality of Life after Phacoemulsification in Patients with Diabetes Mellitus [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 303, 12.
- McColm JR, Geisen P, Schaeffer A, Eason E, Hartnett ME (2004). Expression of VEGF and PEDF in a rat model of ROP: VEGF increases more after multiple oxygen fluctuations compared to a single hypoxic episode [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Patel S, Cohen KL, Hartnett ME, Escaravage GK, Armstrong BB, Janowski CM (2004). Phacoemulsification in Patients with Diabetes Mellitus [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 304, 12.
- Hartnett ME (2004). Testing of Visual Acuity and Maximizing Visual Function in Subjects with Chromosomal Abnormalities [Abstract]. World Congress on Chromosome Abnormalities, San Antonio, TX, 12.
- Hartnett ME, Geisen P, McColm JR (2004). Effects of Leukemia Inhibitory Factor on Rat Retinal Vascular Development [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 1907, 78.
- McColm JR, Geisen P, Hartnett ME (2004). Exogenous LIF Attenuates Retinal Vascularization in Rat [Abstract]. Symposium on Retinal and Choroidal Angiogenesis Meeting. Nashville, TN.
- Hartnett ME (2004). Assessing Visual Acuity in Development [Abstract]. World Congress Symposium. San Antonio, TX.
- Geisen P, Simhan J, McColm JR, Hartnett ME (2004). Intravitreous Injection of Triamcinolone Reduces Extent of Retinal Neovascularization in a Rat Model of OIR [Abstract]. Symposium on Retinal and Choroidal Angiogenesis Meeting. Nashville, TN.
- McColm J, Hartnett ME (2003). VEGF Isoforms and PEDF MRNA Expression in a Rat Model of ROP [Abstract]. 3rd International Symposium on ROP Meeting (AAO), Anaheim, CA.
- Hartnett ME, McColm J (2003). Retinal Features Predictive of Progression to Stage 4 ROP [Abstract]. 3rd International Symposium on ROP Meeting (AAO), Anaheim, CA.
- Hartnett ME, Maguluri S, Thompson H (2003). Comparison of Retinal Outcomes after Lens-Sparing Vitrectomy or Scleral Buckle Stage 4 Retinopathy of Prematurity [Abstract]. 3rd International Symposium on ROP Meeting (AAO), Anaheim, CA.
- Maguluri S, Daccache A, Loyacano N, Massare S, Thompson HW, Hartnett ME (2003). Comparison Between Digital Fundus Imaging and Fundus Examination in Treatment Recommendations for Diabetic Retinopathy [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 4001, 165.
- Namuduri K, Thompson HW, Hartnett ME (2003). A Multiscale-Multiresolution Method for Automated Retinal Feature Detection [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 4009, 165.
- Hartnett ME, Lappas A, Darland DC, McColm JR, DAmore P (2003). Endothelial Cells in Close Proximity to Retinal Pigment Epithelium Causes Outer Retinal Barrier Dysfunction via a Soluble VEGF-Dependent Mechanism [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 3923, 162.
- Daccache A, Maguluri S, Thompson H, Hartnett ME (2003). Comparison of Lens-sparing Vitectomy and Scleral Buckling in Stage 4 Retinopathy of Prematurity [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 308, 25.
- Hartnett ME, DeSalvo K, Key J, Loyacano N (December 4, 2002). Exploring Barriers to Diabetic Eye Care [Abstract]. Sixth Annual Forum on Health Care Effectiveness, Baton Rouge, LA.
- Hartnett ME, DeSalvo K, Key J, Loyacano N (December 3, 2002). Patient and Physician Perceptions of Barriers to Diabetic Eye Care [Abstract]. LSU Health Services Research Program Annual Conference, Baton Rouge, LA.
- Hartnett ME, DeSalvo K, Key J, Loyacano N (November 18, 2002). Exploring Barriers to Diabetic Eye Care [Abstract]. North American Primary Care Research Group 2002 Annual Meeting “Building Research Capacity;” New Orleans, LA.
- Maguluri S, Khoobehi B, Hartnett ME, Carnahan LG, Grinstead RL, Elzembely HA (2002). Iris neovascularization model and an innovative imaging technique for visualization of individual iris vessels [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Photo-ROP Study Group (2002). Inadvertent skip areas in treatment of zone 1 retinopathy of prematurity [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Hartnett ME (2002). Vision after surgery for stages 4 and 5 retinopathy of prematurity as measured by teller acuity cards and the new light perception projection scale [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Coats DK, The Photo-ROP Study Group (2001). Design and Methodology of the Internet-Based ROP Photographic Screening Trial [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Capone A, The Photo-ROP Study Group (2001). The Photo-ROP Trial: an internet-based multicenter trial [Abstract]. American Academy of Ophthalmology International Meeting, New Orleans, LA.
- Miura M, Elsner AE, Kunze C, Beausencourt E, Hartnett, ME, Lashkari K, Trempe CL (2001). Blind grading of infrared scanning laser tomography and color fundus photography in exudative age-related macular degeneration [Abstract]. Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL.
- Lovejoy SM, Darland DC, DAmore PA, Hartnett ME (2001). Contact with endothelial cells (EC) inhibits differentiation of bovine and retinal pigmented epithelium (RPE) in culture -abstract # 1203 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 42 (Suppl).
- Capone A, The Photo-ROP Study Group (2001). What's new in ROP management? [Abstract]. American Academy of Ophthalmology International Meeting, New Orleans, LA.
- Hartnett ME, Rosner B, Vincent DJ (2001). Retinal features associated with retinal attachment in stage 4 and 5 retinopathy of prematurity- abstract # 3672 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 42 (Suppl).
- Miura M, Elsner AE, Beausencourt E, Kunze C, Lashkari K, Hartnett ME, Trempe CL, Hirose T (2000). Cross-sectional analysis of age-related macular degeneration with confocal scanning laser tomography- abstract # 839 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 41 (Suppl), S162.
- Hartnett ME, Garcia CM, DAmore PA (2000). Effects of growth factors and cell-cell interactions on blood-retinal barrier function- abstract # 2170 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 41 (Suppl), S411.
- Kunze C, Moraes L, Elsner AE, Hartnett ME (November 8-11, 1998). Retinal sensitivity in pigment epithelial detachments (PEDs) correlates with three-dimensional extent [Abstract]. American Academy of Ophthalmology National Meeting, New Orleans, LA, 166.
- Moraes L, Elsner AE, Kunze C, Trempe CL, Hartnett ME (1998). Correlation in patients with age-related maculopathy between retinal sensitivity and anatomic abnormalities using a scanning laser ophthalmoscope- abstract # 2745 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 39(Suppl), S593.
- Moraes L, Hartnett ME, Beausencourt E, Kunze C, Elsner AE (October 25-29, 1997). Improved detection in occult choroidal neovascularization associated with age-related macular degeneration [Abstract]. American Academy of Ophthalmology National Meeting, San Francisco, CA, 209.
- Beausencourt E, Elsner AE, Hartnett ME, Trempe CL (October 25-29, 1997). Radial retinal folds in macular holes imaged with scanning laser tomography [Abstract]. American Academy of Ophthalmology National Meeting, San Francisco, CA, 187.
- Beausencourt E, Elsner AE, Hartnett ME, Morales L (October 25-29, 1997). New objective measurements of pigment epithelial detachment in age-related macular degeneration using scanning laser tomography [Abstract]. American Academy of Ophthalmology National Meeting, San Francisco, CA, 187.
- Moraes L, Elsner AE, Kunze CW, Hartnett ME, Trempe CL (1997). Correlation between scanning laser ophthalmoscope perimetry and anatomic abnormalities in patients with age-related maculopathy [Abstract]. American Academy of Perimetry, San Francisco, CA.
- Elsner AE, Hartnett ME, Weiter JJ, Buzney SM, Beausencourt E, Morandi AJ, Trempe CL (1997). Foveal cone photopigment distribution in age-related macular degeneration: association with fundus features- abstract # 4484 [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 38(Suppl), S967.
- Hartnett ME (November 21-22, 1996). Ophthalmology and occupational therapy: collaborating for value [Abstract]. MAOT Conference, Partnerships through Productivity, Marlborough, MA.
- Elsner AE, Burns SA, Weiter J, Hartnett ME (November 1994). Imaging and function evaluation with the scanning laser ophthalmoscope [Abstract]. International Congress of Eye Research: Proceedings of the International Society for Eye Research, New Delhi, India.
- Elsner AE, Burns SA, Weiter J, Hartnett ME (1994). Imaging and function evaluation with the scanning laser ophthalmoscope [Abstract]. Exp Eye Res, 59, 68.
- Hartnett ME, Hirose T, Richardson TM (1992). Aqueous outflow measurement to aid in early glaucoma detection in severe retinopathy of prematurity (ROP) [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 33(Suppl), 1086.
- Hartnett ME, Sang DN, Soque J, Hirose T (1990). Histologic characterization of early premature infant and adult iris tissue [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 31(Suppl), 154.
- Shapiro MJ, Hartnett ME, Lin JT, Johnson MR, Pruett RC (1989). Ocular compatibility of alloplastic materials for scleral surgery [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 30(Suppl), 271.
- Hartnett ME, Johnson MR, Weiter JJ, Jalkh A (1989). Classification of RPE detachments in age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 30(ARVO Suppl), 271.
- Hartnett ME, Gilbert MM, Richardson TM, Krug JH, Hirose T (1989). Intraocular pressure measurements in Stage V retinopathy of prematurity [Abstract]. Ophthalmology, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 96(AAO Suppl), 133.
- Hartnett ME, Gilbert MM, Krug JH, Richardson TM, Hirose T (November 8-11, 1988). Anterior segment evaluation in infants with retinopathy of prematurity [Abstract]. American Academy of Ophthalmology National Meeting, New Orleans, LA, 167.
- Hartnett ME, Jalkh AE, Weiter JJ (November 8-11, 1988). Classification of RPE detachments in age-related macular degeneration [Abstract]. American Academy of Ophthalmology National Meeting, New Orleans, LA, 180.
- Gilbert MM, Hartnett ME, Richardson TM, Krug JH, Hirose T (November 1988). Retinopathy of prematurity: overview and findings in the anterior segment of affected eyes [Abstract]. Pediatric Festshrift, Tampa, FL.
- Hartnett M, Lazarus H, Murphy B, Reed M, Lass J (1987). Topical cortoisteroid versus 2-deoxycytidine therapy of systemic Ara-C induced keratitis [Abstract]. Invest Ophthalmol Vis Sci, Association for Research in Vision and Ophthalmology International Meeting, Fort Lauderdale, FL, 28(ARVO Suppl), 308.
- Mangan KF, Winkelstein SA, Hartnett ME, Matis SA (1982). Natural killer cells regulate human erythropoiesis in vitro [Abstract]. Central Society for Clinical Research.
Other
- Simmons AB, Bretz CA, Wang H, Kunz E, Hajj K, Kennedy C, Yang Z, Suwanmanee T, Kafri T, Hartnett ME (2018 Jun 25). Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.LID - 10.1007/s10456-018-9626-5 [doi]. Angiogenesis. Germany.
- Vegunta Sm, Hwang ES, Hartnett ME (). Central Serous Chorioretinopathy - Case Report.
- Hartnett ME (). Invited article: Advancing technology helpful in pediatric retinal ophthalmology cases. Ophthalmic Surgery News.
- Hartnett ME as consultant (September 2008). Pharmacotherapy Targeting Ocular Neovascularization (invited publication). Focal Points AAO (26(7)).
- Hartnett ME (November 2007). Risk Factors in AMD: Insight from Studies on Environmental Risk Factors, Genotype, and VEGF (invited publication). AMD Update/Ophthalmology Management.
- Hartnett ME (Summer/Fall 2006). An investigation of retinal nonperfusion and its inhibition: A strategy to prevent proliferative diabetic retinopathy (invited publication). Forefront (3(2), pp. 11-13). American Diabetes Association.
- Abelson M, Hartnett ME, McLaughlin J (October 2006). Cutting-Edge Therapies for Wet AMD. Review: Therapeutic Topics (invited publication). Review of Ophthalmology (pp. 100-102).
- Hartnett ME (2005). Differences in Perceived Barriers to Diabetic Eye Care (invited publication). Diabetic Microvascular Complications Today (2, pp. 29-31).
- Hartnett ME (2005). Lesion characteristics important in assessing therapies for AMD (invited publication). Ocular Surgery News (Europe Asia-Pacific Edition adapted from USA version 16:6, 2005) (23(5), pp. 46-50).
- Hartnett ME, Wallace D (7/28/04). Retinopathy of prematurity is the common cause of infant blindness (invited publication). UNC Health Care, featured in News 14 Carolina.
- Hartnett ME (2004). Managing retinopathy of prematurity (invited publication). EyeNet Magazine (8, pp. 35-36).
- Hartnett ME (2004). AMD and the generalist (invited publication, also translated into Spanish and republished in December 2004). Review of Ophthalmology (11, pp. 34-41).
- Hartnett ME, Hirose T, Gilbert MM, Richardson TM, Katsumi O (1994). Glaucoma as a cause of poor vision in severe retinopathy of prematurity (invited publication). Ophthalmology Digest (3, pp. 3-4).
Video/Film/CD/Web/Podcast
- Hartnett ME, Loyacano N (2002). Retinopathy of Prematurity [Web]. Association of Technical Personnel in Ophthalmology, Internet-based online Learning CME Article. Available: http://www.atpo.org/.
- Hartnett ME (June 5-6, 1996). Pertinence of a vitreoretinal surgical simulator [Video]. Syracuse, NY: Sixth Annual Dual-Use Technologies & Applications Conference.
- Hartnett ME (1995). Visual rehabilitation, presentation to occupational therapists, audio and video [Video]. Spaulding Rehabilitation Hospital.
- Hartnett ME (1994). Current concepts in retinopathy of prematurity, presentations to vision teachers. audio & video [Video]. Boston, MA: Perkins School for the Blind.